中国肿瘤生物治疗杂志2017，Vol.24Issue(12)：1350-1355,6.DOI:10.3872/j.issn.1007-385x.2017.12.002
T细胞免疫球蛋白黏蛋白分子-3在肿瘤免疫中的作用和机制
Current understanding of the role of T cell immunoglobulin and mucin-containing protein-3 in cancer immunity
摘要
Abstract
The application of monoclonal antibodies to block immune checkpoints including PD-1,CTLA-4 has demonstrated a good efficacy in cancer immunotherapy.However,some patients poorly responded to these immune checkpoints blockers.One probable mechanism for this failure in igniting the antitumor effect was that other inhibitory molecules over expressed in these cases.As an immune checkpoint,T cell immunolobulin and mucin-containing protein-3(TIM-3) is widely expressed in a variety of immune cells,and palys an important role in the regulation of immune response.Many studies showed that lymphocytes from patient peripheral blood or tumor-infiltrating lymphocytes expressed high levels of TIM-3,which was associated with poor outcome.T cell,DC cell and mononuclear phagocytes with over-expressed TIM-3 showed significant inhibitory effects on antitumor immune response.In preclinical studies,combined blockade of TIM-3 and PD-1 with antibodies showed a synergistic effect on antitumor immunity.Clinical trials are underway to evaluate the safety and efficacy of TIM-3 monoclonal antibodies in cancer patients.However,the regulatory role of TIM-3 on immune cells has not been fully clarified,better understanding of the immune modulatory mechanism of TIM-3 helps to develop effective treatment strategy of blockade of TIM-3 in future clinical trials.关键词
肿瘤免疫/免疫检查点/T细胞免疫球蛋白黏蛋白分子-3Key words
cancer immunity/immune checkpoint/T cell immunoglobulin and mucin-containing protein-3分类
医药卫生引用本文复制引用
姜霁峰,陶荣..T细胞免疫球蛋白黏蛋白分子-3在肿瘤免疫中的作用和机制[J].中国肿瘤生物治疗杂志,2017,24(12):1350-1355,6.基金项目
上海市教育委员会高峰高原学科建设资助项目(No.20152219). Project supported by Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant (No.201522119) （No.20152219）
